Paige: First European regulatory clearance for Paige’s digital biomarker capabilities NEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD and UKCA marks for the...

Paige: Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry NEW YORK–(BUSINESS WIRE)–Paige, a global leader in AI applications in pathology, today...

Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of...

Paige now holds six CE marks in its portfolio of clinical AI applications Paige Breast Lymph Node was first launched at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in March 2022 NEW YORK--(BUSINESS...

NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today launched its latest product, Paige Breast Lymph Node, an AI medical device software that helps pathologists detect if breast cancer has...

Upcoming Paige Webinar Going Digital in Pathology Key Factors to Consider Before the Transition Tuesday, March 15, 2022 | 13:00 GMT/ 8:00 AM EST Register Now Tuesday, March 15,...